Occudo Quantitative Strategies LP Procept Bio Robotics Corp Transaction History
Occudo Quantitative Strategies LP
- $501 Million
- Q3 2024
A detailed history of Occudo Quantitative Strategies LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 3,529 shares of PRCT stock, worth $251,441. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,529
Previous 17,444
79.77%
Holding current value
$251,441
Previous $1.07 Million
73.52%
% of portfolio
0.06%
Previous 0.2%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
275Shares Held
39.6MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$345 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$248 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$109 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$88.6 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$84 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.18B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...